Welcome to our dedicated page for Lifeway Food SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lifeway Foods Inc. filings document the regulatory record for an Illinois operating company whose common stock trades on the Nasdaq Global Market under the symbol LWAY. Its Form 8-K reports cover operating results, sales estimates, Regulation FD disclosures, material agreements, director appointments and resignations, and compensatory arrangements under the company's 2022 Omnibus Incentive Plan.
Proxy materials describe annual shareholder meeting matters, board and committee governance, executive compensation and equity-plan administration. The filing record also identifies the company's registered securities, including common stock and preferred stock purchase rights, and includes formal disclosures related to financial reporting, governance changes and capital-structure matters.
Juan Carlos Dalto, a director of Lifeway Foods, Inc. (LWAY), reported changes in his holdings tied to director compensation and previously granted awards. The filing shows a disposition of 4,751 shares of common stock and the acquisition (by vesting or deferral) of derivative awards that translate to 2,815 shares of common stock: 1,600, 3,101, and 2,710 RSU tranches (with portions deferred or contingent on continued service) and 541 shares of phantom stock acquired via deferral of cash board fees. Many RSUs are vested but settlement has been deferred under the company’s Non-Employee Director Equity and Deferred Compensation Plan; deferred awards become payable when the reporting person ceases to serve as a director. Some RSU tranches remain time‑vesting and are contingent on continued board service.
Lifeway Foods insider intends to sell 26,847 common shares (approximately $697,586.60 in aggregate market value) through Merrill Lynch on NASDAQ around 10/01/2025. The filing shows all 26,847 shares were acquired as compensation from the issuer on multiple dates between 07/28/2005 and 07/01/2025. The total number of outstanding shares is listed as 15,226,520, and the transaction will be executed via broker-dealer Merrill Lynch at 75 Rockefeller Plaza, New York.
Lifeway Foods, Inc. disclosed that board member Jody Levy resigned from the company’s Board of Directors, effective October 1, 2025. The company states that her resignation did not result from any disagreement with its operations, policies, or practices, indicating an orderly board change.
Danone holds 3,454,756 shares of Lifeway Foods, representing 22.7% of the outstanding common stock based on 15,226,520 shares. This filing is Amendment No. 11 to Danone's long‑standing Schedule 13D and reports a Letter Agreement dated September 30, 2025 between Danone North America PBC and Lifeway. The Letter Agreement is designed to give Danone additional optionality to sell its stake and, among other things, requires Lifeway to maintain a shelf registration to facilitate potential sales, contemplates appointment of three independent directors within 30 days and a fourth within 45 days acceptable to Danone, contemplates an independent board chair, contains voting commitments by Danone subject to exceptions, seeks a joint effort to stay pending litigation, and includes mutual non‑disparagement and Stockholders' Agreement compliance provisions.
Lifeway Foods, Inc. disclosed changes to its agreements with Danone that limit Danone's involvement in corporate governance and certain transfer restrictions. Danone will not need to consent for the company to grant market‑term equity compensation to management (excluding JS, her immediate family and affiliates) provided the Compensation Committee—with a majority of New Independent Directors—approves the grants. Danone also waived its rights to board and committee representation and agreed to waive rights of first refusal on certain monthly sales by ES, LS and JS of up to 100,000 shares each, subject to those parties waiving claims related to shares held by Michael Smolyansky's estate. Danone's remaining Stockholders' Agreement rights (other than registration and books-and-records rights) will end once Danone and affiliates hold fewer than 761,438 shares (adjusted for recapitalizations).
Edward Smolyansky, a director of Lifeway Foods, Inc. (LWAY), reported open-market sales of common stock on 09/23/2025 and 09/24/2025. He sold 6,357 shares on 09/23/2025 at a weighted average price of $26.53 and 10,000 shares on 09/24/2025 at a weighted average price of $26.69, reducing his direct holdings to 1,235,285 shares. The filing also discloses multiple indirect holdings: 75,000 shares held by a family foundation, 1,233,333 shares in a trust for which he is trustee, 100,000 shares owned by his son (disclaimed), and 500,000 shares held by Smolyansky Holding LLC (partially disclaimed). The form is signed and dated 09/25/2025.
Lifeway Foods (LWAY) submitted a Form 144 disclosing a proposed sale of 10,000 shares of common stock through Citigroup Global Markets, slated for 09/24/2025, with an aggregate market value of $266,914 and 15,226,520 shares outstanding. The filing states the securities were acquired on 05/19/2023 from Ludmila Smolyansky for cash, showing an acquisition amount of 3,197,975 shares on that date. The notice also reports a recent sale: Edward Smolyansky sold 6,357 shares on 09/23/2025 for $168,653.75. The filer affirms no undisclosed material adverse information.
Form 144 notice for Lifeway Foods, Inc. (LWAY) shows a proposed sale of 6,357 shares of common stock through Citigroup Global Markets Inc. on 09/23/2025 on NASDAQ with an aggregate market value of $168,653.75. The filing reports that the securities were acquired on 05/19/2023 by purchase from Ludmila Smolyansky and that 3,197,975 shares were acquired on that date for cash. The total number of shares outstanding is listed as 15,226,520. Several issuer-identifying fields (issuer name, address, and the specific name of the person for whose account the securities are to be sold) are not provided in the visible content of this form.
Form 144 notice for Lifeway Foods, Inc. (LWAY) shows a proposed sale of 6,357 shares of common stock through Citigroup Global Markets Inc. on 09/23/2025 on NASDAQ with an aggregate market value of $168,653.75. The filing reports that the securities were acquired on 05/19/2023 by purchase from Ludmila Smolyansky and that 3,197,975 shares were acquired on that date for cash. The total number of shares outstanding is listed as 15,226,520. Several issuer-identifying fields (issuer name, address, and the specific name of the person for whose account the securities are to be sold) are not provided in the visible content of this form.
Lifeway Foods, Inc. filed a current report to note that it issued a press release on September 18, 2025. The company used a Regulation FD disclosure item and attached the press release as Exhibit 99.1, making it available to the public through this filing.
Lifeway Foods, Inc. filed a current report to note that it issued a press release on September 18, 2025. The company used a Regulation FD disclosure item and attached the press release as Exhibit 99.1, making it available to the public through this filing.
Danone entities report a 22.7% stake in Lifeway Foods (3,454,756 shares) and amend their Schedule 13D to update intentions. Danone North America entered a confidentiality agreement with Lifeway on August 1, 2025 to review a potential acquisition but on September 17, 2025 determined it would no longer pursue an acquisition and notified Lifeway. Danone is now reviewing alternatives for its investment, which may include selling or holding its shares, or voting for proposals in a pending consent solicitation to replace Lifeway's board; no final decisions have been made.
Danone entities report a 22.7% stake in Lifeway Foods (3,454,756 shares) and amend their Schedule 13D to update intentions. Danone North America entered a confidentiality agreement with Lifeway on August 1, 2025 to review a potential acquisition but on September 17, 2025 determined it would no longer pursue an acquisition and notified Lifeway. Danone is now reviewing alternatives for its investment, which may include selling or holding its shares, or voting for proposals in a pending consent solicitation to replace Lifeway's board; no final decisions have been made.